True carcinosarcoma of the esophagus

被引:15
作者
Iwaya, T
Maesawa, C
Uesugi, N
Kimura, T
Ogasawara, S
Ikeda, K
Kimura, Y
Mitomo, S
Ishida, K
Sato, N
Saito, K
Masuda, T
机构
[1] Iwate Med Univ, Sch Med, Dept Surg 1, Morioka, Iwate 0208505, Japan
[2] Iwate Med Univ, Sch Med, Dept Pathol, Morioka, Iwate 0208505, Japan
[3] Iwate Med Univ, Sch Med, Div Pathol, Cent Clin Lab, Morioka, Iwate 0208505, Japan
[4] Iwate Med Univ, Sch Med, Dept Crit Care Med, Morioka, Iwate 0208505, Japan
关键词
collision tumor; esophagus; osteosarcoma; p53; true carcinosarcoma;
D O I
10.1111/j.1442-2050.2006.00538.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Most esophageal carcinosarcomas are diagnosed as so-called carcinosarcoma, in which individual elements may be derived from a single common ancestor cell, and there have been a few reports describing true carcinosarcoma originating from two individual stem cells. We describe a case of esophageal carcinosarcoma exhibiting neoplastic osteoid formation. Immunoreactivity for vimentin and p53 was limited to only the sarcomatous component and was absent in the carcinomatous component. Furthermore, a point mutation in exon 7 of the p53 gene was observed only in the sarcomatous component. Both sarcoma and carcinoma cells distinctively metastasized to different lymph nodes. These observations led us to diagnose the esophageal tumor as a true carcinosarcoma.
引用
收藏
页码:48 / 52
页数:5
相关论文
共 20 条
[1]   SARCOMATOID CARCINOMA - AN ULTRASTRUCTURAL-STUDY WITH LIGHT-MICROSCOPIC AND IMMUNOHISTOCHEMICAL CORRELATION OF 10 CASES FROM VARIOUS ANATOMIC SITES [J].
BALERCIA, G ;
BHAN, AK ;
DICKERSIN, GR .
ULTRASTRUCTURAL PATHOLOGY, 1995, 19 (04) :249-263
[2]   Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[3]  
GEISINGER KR, 1987, CANCER-AM CANCER SOC, V59, P1781, DOI 10.1002/1097-0142(19870515)59:10<1781::AID-CNCR2820591017>3.0.CO
[4]  
2-3
[5]  
HANADA M, 1984, ACTA PATHOL JAPON, V34, P669
[6]   Esophageal carcinosarcoma: A genetic analysis [J].
Iwaya, T ;
Maesawa, C ;
Tamura, G ;
Sato, N ;
Ikeda, K ;
Sasaki, A ;
Othuka, K ;
Ishida, K ;
Saito, K ;
Satodate, R .
GASTROENTEROLOGY, 1997, 113 (03) :973-977
[7]  
IYOMASA S, 1990, JPN J CLIN ONCOL, V20, P99
[8]   Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: A genetic study with special reference to histogenesis [J].
Jin, Z ;
Ogata, S ;
Tamura, G ;
Katayama, Y ;
Fukase, M ;
Yajima, M ;
Motoyama, T .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (04) :368-373
[9]   A case of esophageal sarcomatoid carcinoma with molecular evidence of a monoclonal origin [J].
Kashiwabara, K ;
Sano, T ;
Oyama, T ;
Najahima, T ;
Makita, F ;
Hashimoto, N ;
Iwanami, K ;
Kawashima, O ;
Matsumoto, T ;
Matsuzaki, Y .
PATHOLOGY RESEARCH AND PRACTICE, 2001, 197 (01) :41-46
[10]   ABERRATIONS OF TUMOR-SUPPRESSOR GENES (P53, APC, MCC AND RB) IN ESOPHAGEAL SQUAMOUS-CELL CARCINOMA [J].
MAESAWA, C ;
TAMURA, G ;
SUZUKI, Y ;
OGASAWARA, S ;
ISHIDA, K ;
SAITO, K ;
SATODATE, R .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (01) :21-25